Barnes-jewish St Peters Hospital | |
10 Hospital Dr, Saint Peters, Missouri 63376 | |
(636) 916-9000 | |
Name | Barnes-jewish St Peters Hospital |
---|---|
Type | Acute Care Hospital |
Location | 10 Hospital Dr, Saint Peters, Missouri |
Ownership | Voluntary non-profit - Other |
Emergency Services | Yes |
Medicare ID (CCN) | 260191 |
NPI Number | 1144238908 |
Organization Name | BARNES JEWISH ST PETERS HOSPITAL INC |
Doing Business As | BARNES-JEWISH ST PETERS HOSPITAL |
Address | 10 Hospital Dr, Saint Peters, MO 63376 |
Hospital Type | General Acute Care Hospital |
Phone Number | 636-916-9000 |
News Archive
Furiex Pharmaceuticals, Inc. announced today that it has acquired full exclusive license rights to develop and commercialize the compound JNJ-Q2 under its existing development and license agreement with Janssen Pharmaceutica N.V.. Furiex acquired these rights as a result of Janssen's decision not to exercise its option under the agreement that gave Janssen the opportunity to continue development of JNJ-Q2.
In this post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, published in partnership with Women Deliver as part of a series on youth perspectives to recognize World Contraception Day, observed annually on September 26, youth activist Cecilia Garcia Ruiz writes, "For six years we've worked to shine a spotlight on these key issues, but some people still disregard the importance of providing universal access to quality contraceptive services and information to prevent unplanned pregnancies, especially among young people."
The United Nations Foundation (UN Foundation) announced today that it has received a US$139 million contribution from the GAVI Alliance to support the worldwide effort by the Measles Initiative to reduce measles deaths by 90 percent by 2010.
RaySearch Laboratories AB has been awarded a contract for a new adaptive radiation therapy solution at Princess Margaret Hospital (PMH) in Toronto, Canada. This means that RaySearch will deliver its treatment planning system RayStation to PMH where it will be used as the primary treatment planning tool for adaptive radiation therapy.
Well, its probable (although not certain) that, within two or three decades, the Social Security trust fund will be exhausted, leaving the system unable to pay the full benefits specified by current law. So the plan is to avoid cuts in future benefits by committing right now to ... cuts in future benefits. Huh? O.K., you can argue that the adjustment to an aging population would be smoother if we commit to a glide path of benefit cuts now. On the other hand, by moving too soon we might lock in benefit cuts that turn out not to have been necessary.
› Verified 8 days ago
Able to receive lab results electronically | Yes |
Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
Furiex Pharmaceuticals, Inc. announced today that it has acquired full exclusive license rights to develop and commercialize the compound JNJ-Q2 under its existing development and license agreement with Janssen Pharmaceutica N.V.. Furiex acquired these rights as a result of Janssen's decision not to exercise its option under the agreement that gave Janssen the opportunity to continue development of JNJ-Q2.
In this post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, published in partnership with Women Deliver as part of a series on youth perspectives to recognize World Contraception Day, observed annually on September 26, youth activist Cecilia Garcia Ruiz writes, "For six years we've worked to shine a spotlight on these key issues, but some people still disregard the importance of providing universal access to quality contraceptive services and information to prevent unplanned pregnancies, especially among young people."
The United Nations Foundation (UN Foundation) announced today that it has received a US$139 million contribution from the GAVI Alliance to support the worldwide effort by the Measles Initiative to reduce measles deaths by 90 percent by 2010.
RaySearch Laboratories AB has been awarded a contract for a new adaptive radiation therapy solution at Princess Margaret Hospital (PMH) in Toronto, Canada. This means that RaySearch will deliver its treatment planning system RayStation to PMH where it will be used as the primary treatment planning tool for adaptive radiation therapy.
Well, its probable (although not certain) that, within two or three decades, the Social Security trust fund will be exhausted, leaving the system unable to pay the full benefits specified by current law. So the plan is to avoid cuts in future benefits by committing right now to ... cuts in future benefits. Huh? O.K., you can argue that the adjustment to an aging population would be smoother if we commit to a glide path of benefit cuts now. On the other hand, by moving too soon we might lock in benefit cuts that turn out not to have been necessary.
› Verified 8 days ago
Barnes-jewish St Peters Hospital Acute Care Hospital Location: 10 Hospital Dr, Saint Peters, Missouri 63376 Phone: (636) 916-9000 |